A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
24 February, 2026
First patient recruited for trial of new imaging modality for lung cancer
LATEST NEWS: 24 February 2026 The first Australian participant
